Home » Stocks » APVO » Financials

Aptevo Therapeutics Inc. (APVO)

Stock Price: $23.52 USD 0.07 (0.30%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year20202019201820172016201520142013
Revenue4.31-23.0714.669.9933.6045.630.17
Revenue Growth--57.37%46.8%-70.28%-26.36%26741.76%-
Cost of Revenue--11.215.0112.4716.9316.25-
Gross Profit4.31-11.859.65-2.4816.6729.380.17
Selling, General & Admin13.9516.2028.1334.5836.1643.0434.2815.45
Research & Development17.8524.7635.3929.0229.1234.7346.5938.07
Other Operating Expenses0.000.000.000.0071.010.000.22-0.02
Operating Expenses31.8040.9663.5263.6013677.7781.0953.51
Operating Income-27.49-40.96-51.67-53.95-139-61.10-51.71-53.34
Other Expense / Income-9.74-0.512.02-37.62-6.670.240.000.00
Pretax Income-17.75-40.45-53.69-16.33-132-61.34-51.71-53.34
Income Tax----23.30-19.69-2.02-0.60-
Net Income-17.75-40.45-53.696.97-112-59.32-51.12-53.34
Shares Outstanding (Basic)3.392.921.611.521.451.44--
Shares Outstanding (Diluted)3.392.921.611.521.451.44--
Shares Change16.25%81.5%5.46%5.42%0.05%---
EPS (Basic)-5.23-13.86-33.464.62-77.70-41.02--
EPS (Diluted)-5.23-13.86-33.464.62-77.70-41.02--
Free Cash Flow Per Share-8.67-14.58-32.60-28.20-27.24-34.80--
Gross Margin100%-51.4%65.8%-24.9%49.6%64.4%100%
Operating Margin-638.1%--224.0%-368.1%-1,389.8%-181.8%-113.3%-31,374.7%
Profit Margin-411.9%--232.8%47.6%-1125.8%-176.5%-112%-31374.7%
FCF Margin-682.4%--227.2%-293.2%-394.3%-149.7%-105.2%-30,831.2%
EBITDA-16.34-38.21-51.30-13.20-129-58.43-49.69-52.67
EBITDA Margin-379.3%--222.4%-90.1%-1289.4%-173.9%-108.9%-30982.9%
EBIT-17.75-40.45-53.69-16.33-132-61.34-51.71-53.34
EBIT Margin-411.9%--232.8%-111.4%-1,323.1%-182.5%-113.3%-31,374.7%